Edition:
India

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

2.86USD
17 Aug 2018
Change (% chg)

$0.17 (+6.32%)
Prev Close
$2.69
Open
$2.66
Day's High
$2.91
Day's Low
$2.65
Volume
211,995
Avg. Vol
261,814
52-wk High
$6.66
52-wk Low
$2.24

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.12 December 19 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 1 1
(2) OUTPERFORM 1 1 1 1
(3) HOLD 3 3 3 4
(4) UNDERPERFORM 1 1 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 2.40 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 0.88 2.00 0.00 1.27
Quarter Ending Dec-18 5 0.88 2.00 0.00 1.27
Year Ending Dec-18 4 0.62 1.60 0.15 5.93
Year Ending Dec-19 4 3.95 6.00 0.58 62.53
Earnings (per share)
Quarter Ending Sep-18 5 -0.12 -0.07 -0.14 -0.15
Quarter Ending Dec-18 5 -0.12 -0.08 -0.14 -0.15
Year Ending Dec-18 5 -0.50 -0.42 -0.55 -0.59
Year Ending Dec-19 5 -0.37 -0.22 -0.50 -0.43

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 1.19 0.00 1.19 100.00
Quarter Ending Mar-18 1.50 0.15 1.36 90.28
Quarter Ending Dec-17 1.59 1.60 0.01 0.41
Quarter Ending Sep-17 1.62 1.60 0.03 1.63
Quarter Ending Jun-17 1.66 1.60 0.06 3.81

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.88 1.20 1.19 1.19 1.27
Quarter Ending Dec-18 0.88 1.20 1.19 1.19 1.27
Year Ending Dec-18 0.62 1.82 3.59 3.49 5.93
Year Ending Dec-19 3.95 4.74 4.74 4.84 62.53

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 1 1 1
Quarter Ending Dec-18 0 1 1 1
Year Ending Dec-18 0 1 0 3
Year Ending Dec-19 0 1 0 1
Earnings